| | Visit 0 | Visit 1 | Visit 2 | Visit 3… | Visit X* | Visit X + 1 | Visit X + 2 | End-point |
|---|
Time | Presentation | 1 month | 2 months | 3 months… | X months | 6 months | 12 months | 24 months |
BCVA | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ |
Slit-lamp examination | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ |
FP | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ | ✖ |
FFA | ✖ | | | | | | | |
OCT | ✖ | | | | ✖ | | | ✖ |
Ancillary tests | ✖ | | | | | | | |
- BCVA best-corrected visual acuity, FP fundus photography, FFA fundus fluorescence angiography. Ancillary tests included visual field test, B-scan ultrasonography, auto-fluorescence of fundus (AF), computed tomography (CT), and magnetic resonance imaging (MRI)
- Visit X*: Monthly follow-up was performed until the hemorrhage had completely resolved. The visit at which hemorrhage absorption was complete was defined as Visit X. If X < 6 months from the time of presentation, the next visit was at 6 months post-presentation (Visit X + 1); if X ≥ 6 months from the time of presentation, the next visit was 12 months post-presentation (Visit X + 2)
